The company has achieved meaningful structural improvement by reducing its debt-to-equity ratio from a peak of 2.72 in 2023Q4 to 1.49 as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | May'02 | May'00 | May'99 | May'98 | May'97 | May'96 | May'95 |
|---|
| Total Current Assets | 8.36B | 7.85B | 7.68B | 7.17B | 5.98B | 7.08B | 7.15B | 5.08B | 4.64B | 5.57B | 5.26B | 5.17B | 4.72B | 3.71B | 2.68B | 2.36B | 2.31B | 2.47B | 2.71B | 2.56B | 3.02B | 3.51B | 3.99B | 4.25B | 3.27B | 3.59B | 3.52B | 2.89B | 2.39B | 1.54B | 1.62B |
| Cash & Short-Term Investments | 2.97B | 2.88B | 3.02B | 1.23B | 858M | 2.36B | 2.45B | 262M | 411M | 611M | 716M | 356M | 193M | 113M | 364M | 113M | 406M | 703M | 523M | 592M | 823M | 1.38B | 771M | 742M | 166M | 245M | 154M | 23M | 35M | 89M | 155M |
| Cash Only | 2.97B | 2.88B | 3.02B | 1.23B | 858M | 2.36B | 2.45B | 262M | 411M | 611M | 716M | 356M | 193M | 113M | 364M | 113M | 405M | 690M | 507M | 572M | 784M | 1.37B | 654M | 619M | 63M | 135M | 31M | 23M | 35M | 89M | 155M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 13M | 16M | 20M | 39M | 5M | 117M | 123M | 103M | 104M | 123M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.6B | 2.56B | 3.05B | 3.4B | 3.46B | 3.31B | 3.35B | 3.26B | 3.09B | 3.02B | 3.43B | 3.09B | 2.4B | 1.89B | 1.34B | 1.28B | 1.29B | 1.2B | 1.46B | 1.56B | 1.73B | 1.6B | 2.22B | 2.42B | 2.38B | 2.39B | 2.47B | 2.32B | 1.74B | 1.35B | 1.04B |
| Days Sales Outstanding | 53.8 | 43.93 | 53.94 | 60.47 | 65.9 | 61.93 | 69.34 | 64.47 | 61.65 | 57.57 | 63.84 | 60.49 | 52.78 | 62.12 | 53.48 | 54.2 | 56.79 | 48.47 | 62.07 | 70.26 | 74.57 | 70.14 | 92.5 | 87.69 | 62.36 | 72.25 | 78.92 | 77.76 | 64.26 | 56.53 | 49.26 |
| Inventory | 343M | 348M | 346M | 411M | 405M | 384M | 368M | 310M | 305M | 289M | 326M | 309M | 276M | 262M | 153M | 161M | 156M | 153M | 161M | 183M | 184M | 190M | 188M | 224M | 220M | 223M | 218M | 214M | 193M | 128M | 116M |
| Days Inventory Outstanding | 10.22 | 33.6 | 10.14 | 11.77 | 12.19 | 11.47 | 11.77 | 9.62 | 9.55 | 8.52 | 9.53 | 9.44 | 9.46 | 13.37 | 9.61 | 37.96 | 36.93 | 10.29 | 11.11 | 13.31 | 12.65 | 13.03 | 12.84 | - | - | 19.02 | 19.31 | 20.2 | 20.44 | 5.96 | 6.67 |
| Other Current Assets | 2.44B | 2.05B | 895M | 1.73B | 856M | 769M | 982M | 1.25B | 827M | 1.65B | 783M | 1.42B | 1.1B | 1.43B | 828M | 725M | 394M | 349M | 481M | 138M | 188M | 340M | 815M | 867M | 507M | 460M | 678M | 1.26B | 911M | 817M | 723M |
| Total Non-Current Assets | 22.85B | 21.83B | 21.25B | 21.14B | 21.18B | 20.5B | 19.96B | 18.27B | 17.77B | 17.81B | 19.44B | 18.51B | 13.42B | 12.42B | 6.36B | 6.11B | 6.19B | 5.48B | 5.46B | 5.83B | 5.51B | 6.3B | 6.09B | 8.05B | 10.15B | 9.57B | 9.76B | 9.94B | 9.31B | 6.79B | 6.29B |
| Property, Plant & Equipment | 6.25B | 6.32B | 7.09B | 7.32B | 7.59B | 7.43B | 7.75B | 7.79B | 6.99B | 7.03B | 8.05B | 7.92B | 7.73B | 7.69B | 4.29B | 4.35B | 4.3B | 4.31B | 4.29B | 4.64B | 4.3B | 4.62B | 4.82B | 5.56B | 6.31B | 5.89B | 5.84B | 6.01B | 5.49B | 3.65B | 3.32B |
| Fixed Asset Turnover | 3.48x | 3.37x | 2.92x | 2.81x | 2.53x | 2.62x | 2.27x | 2.37x | 2.62x | 2.73x | 2.44x | 2.35x | 2.15x | 1.44x | 2.12x | 1.99x | 1.92x | 2.09x | 2.00x | 1.74x | 1.97x | 1.80x | 1.82x | 1.81x | 2.21x | 2.04x | 1.95x | 1.81x | 1.80x | 2.38x | 2.32x |
| Goodwill | 11.39B | 11.2B | 10.69B | 10.31B | 10.12B | 9.26B | 8.81B | 7.25B | 7.28B | 7.02B | 7.42B | 6.97B | 3.91B | 3.04B | 916M | 736M | 652M | 607M | 609M | 607M | 601M | 800M | 800M | 0 | 3.32B | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.32B | 1.35B | 1.4B | 1.37B | 1.42B | 1.5B | 1.6B | 1.6B | 1.73B | 1.77B | 1.84B | 1.68B | 1.28B | 1.19B | 650M | 489M | 442M | 379M | 323M | 293M | 231M | 241M | 144M | 2.11B | 166M | 3.33B | 3.37B | 3.41B | 3.15B | 2.57B | 2.51B |
| Long-Term Investments | 8.82B | 2.88B | 1.81B | 1.89B | 1.83B | 2.03B | 1.23B | 1.19B | 1.23B | 1.28B | 984M | 1.18B | 133M | 118M | 162M | 45M | 53M | 57M | 242M | 288M | 0 | 380M | 155M | 185M | 360M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3.81B | 84M | 194M | 180M | 192M | 224M | 239M | 264M | 229M | 263M | 266M | 0 | 447M | 486M | 0 | 184M | 181M | 125M | 31M | 35M | 383M | 156M | 166M | -60M | -160M | 344M | 546M | 515M | 678M | 565M | 464M |
| Total Assets | 31.2B | 29.68B | 28.94B | 28.31B | 27.16B | 27.58B | 27.11B | 23.35B | 22.41B | 23.39B | 24.7B | 23.68B | 18.14B | 16.13B | 9.04B | 8.46B | 8.5B | 7.95B | 8.17B | 8.39B | 8.54B | 9.81B | 10.08B | 12.3B | 13.42B | 13.16B | 13.28B | 12.83B | 11.71B | 8.33B | 7.92B |
| Asset Turnover | 0.72x | 0.72x | 0.71x | 0.73x | 0.71x | 0.71x | 0.65x | 0.79x | 0.82x | 0.82x | 0.79x | 0.79x | 0.92x | 0.69x | 1.01x | 1.02x | 0.97x | 1.13x | 1.05x | 0.96x | 0.99x | 0.85x | 0.87x | 0.82x | 1.04x | 0.92x | 0.86x | 0.85x | 0.85x | 1.04x | 0.97x |
| Asset Growth % | 7.51% | 2.56% | 2.2% | 4.26% | -1.53% | 1.75% | 16.08% | 4.2% | -4.17% | -5.33% | 4.3% | 30.54% | 12.47% | 78.35% | 6.88% | -0.45% | 6.88% | -2.7% | -2.61% | -1.71% | -12.97% | -2.64% | -18.05% | -8.38% | 1.99% | -0.86% | 3.44% | 9.64% | 40.48% | 5.23% | 114.17% |
| Total Current Liabilities | 6.15B | 4.46B | 4.31B | 4.76B | 4.48B | 5.11B | 4.85B | 4.21B | 3.86B | 4.33B | 4.03B | 4.31B | 3.58B | 2.93B | 1.76B | 1.81B | 1.73B | 1.78B | 1.95B | 2.05B | 1.93B | 2.29B | 2.13B | 2.39B | 2.23B | 1.91B | 1.93B | 1.77B | 1.87B | 1.13B | 1.36B |
| Accounts Payable | 1.34B | 1.36B | 1.29B | 1.41B | 1.5B | 1.3B | 1.21B | 1.2B | 1.09B | 1.1B | 1.19B | 1.38B | 1.07B | 1.08B | 722M | 760M | 720M | 739M | 686M | 780M | 775M | 857M | 937M | 987M | 803M | 775M | 605M | 713M | 657M | 540M | 530M |
| Days Payables Outstanding | 40.24 | 131.32 | 37.92 | 40.33 | 45.27 | 38.84 | 38.61 | 37.35 | 34.24 | 32.3 | 34.75 | 42.14 | 36.56 | 55.35 | 45.37 | 179.2 | 170.43 | 49.71 | 47.33 | 56.74 | 53.3 | 58.76 | 63.99 | - | - | 66.09 | 53.6 | 67.3 | 69.59 | 25.16 | 30.47 |
| Short-Term Debt | 81M | 79M | 296M | 120M | 145M | 135M | 145M | 171M | 182M | 146M | 191M | 127M | 112M | 153M | 94M | 66M | 67M | 2M | 2M | 1M | 22M | 19M | 41M | 18M | 35M | 25M | 36M | 45M | 10M | 28M | 120M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 110M | 959M | 659M | 61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.64B | 1.81B | 2.55B | 3.01B | 2.5B | 2.51B | 2.59B | 2.52B | 2.23B | 2.75B | 2.3B | 2.3B | 2.05B | 1.66B | 822M | 813M | 815M | 469M | 968M | 1.02B | 537M | 538M | 610M | 669M | 875M | 758M | 1.28B | 1.26B | 1.04B | 1.3B | 891M |
| Current Ratio | 1.36x | 1.76x | 1.78x | 1.51x | 1.34x | 1.38x | 1.47x | 1.21x | 1.20x | 1.29x | 1.30x | 1.20x | 1.32x | 1.27x | 1.52x | 1.30x | 1.34x | 1.39x | 1.39x | 1.25x | 1.57x | 1.53x | 1.87x | 1.77x | 1.47x | 1.88x | 1.83x | 1.64x | 1.28x | 1.36x | 1.20x |
| Quick Ratio | 1.30x | 1.68x | 1.70x | 1.42x | 1.25x | 1.31x | 1.40x | 1.13x | 1.12x | 1.22x | 1.22x | 1.13x | 1.24x | 1.18x | 1.43x | 1.21x | 1.25x | 1.30x | 1.31x | 1.16x | 1.48x | 1.45x | 1.79x | 1.68x | 1.37x | 1.76x | 1.71x | 1.51x | 1.18x | 1.25x | 1.11x |
| Cash Conversion Cycle | 23.78 | -53.79 | 26.16 | 31.91 | 32.82 | 34.56 | 42.5 | 36.74 | 36.97 | 33.79 | 38.63 | 27.78 | 25.68 | 20.14 | 17.72 | -87.04 | -76.71 | 9.05 | 25.85 | 26.84 | 33.92 | 24.41 | 41.35 | - | - | 25.18 | 44.64 | 30.66 | 15.11 | 37.33 | 25.46 |
| Total Non-Current Liabilities | 16.2B | 16.24B | 16.08B | 18.04B | 18.07B | 18.21B | 19.37B | 17.16B | 16.45B | 16.65B | 17.19B | 16.15B | 13.38B | 12.08B | 6.05B | 5.14B | 4.96B | 5.47B | 6.12B | 6.29B | 6.35B | 6.5B | 6.22B | 5.54B | 5.9B | 7.18B | 7.26B | 7.51B | 6.61B | 4.56B | 4.58B |
| Long-Term Debt | 13.13B | 13.09B | 12.69B | 14.88B | 14.93B | 15.51B | 15.57B | 14.58B | 14.64B | 14.79B | 15.06B | 14.38B | 11.51B | 10.7B | 5.16B | 4.29B | 4B | 4.27B | 4.78B | 4.77B | 4.76B | 4.78B | 4.39B | 4.04B | 4.32B | 4.2B | 5.78B | 6.39B | 5.83B | 5.02B | 4.42B |
| Capital Lease Obligations | 0 | 0 | 1.34B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 698M | 0 | 227M | 326M | 217M | 36M | 29M | 27M | 36M | 36M | 279M | 37M | 0 | 0 | 0 | 0 | 0 | 148M | 101M | 119M | 107M | 212M | 311M | 4M | 546M | 491M | 427M | 423M | 308M | 394M | 301M |
| Other Non-Current Liabilities | 2.87B | 3.15B | 1.81B | 2.84B | 2.91B | 2.65B | 2.85B | 2.59B | 1.76B | 1.82B | 1.85B | 1.73B | 1.68B | 1.44B | 889M | 845M | 959M | 1.05B | 1.2B | 1.4B | 1.48B | 1.5B | 1.56B | 1.5B | 1.03B | 994M | 1.05B | 1.05B | 1.26B | 1.28B | 1.1B |
| Total Liabilities | 22.35B | 20.7B | 20.39B | 22.8B | 22.55B | 23.32B | 24.22B | 21.36B | 20.3B | 20.98B | 21.23B | 20.46B | 16.95B | 15.01B | 7.81B | 6.95B | 6.68B | 7.26B | 8.07B | 8.34B | 8.28B | 8.79B | 8.35B | 7.94B | 8.12B | 9.1B | 9.19B | 9.28B | 8.48B | 5.7B | 5.93B |
| Total Debt | 13.21B | 13.17B | 14.33B | 15B | 15.08B | 15.65B | 15.72B | 14.75B | 14.83B | 14.94B | 15.26B | 14.51B | 11.62B | 10.85B | 5.25B | 4.36B | 4.06B | 4.27B | 4.78B | 4.77B | 4.78B | 4.8B | 4.44B | 4.06B | 4.36B | 4.23B | 5.82B | 6.44B | 5.84B | 5.05B | 4.54B |
| Net Debt | 10.24B | 10.29B | 11.31B | 13.77B | 14.22B | 13.28B | 13.27B | 14.49B | 14.41B | 14.33B | 14.54B | 14.15B | 11.42B | 10.74B | 4.89B | 4.25B | 3.66B | 3.58B | 4.27B | 4.2B | 4B | 3.43B | 3.78B | 3.44B | 4.29B | 4.17B | 5.79B | 6.41B | 5.82B | 5.01B | 4.43B |
| Debt / Equity | 1.49x | 1.47x | 1.68x | 2.72x | 3.27x | 3.68x | 5.44x | 7.42x | 7.04x | 6.21x | 4.39x | 4.50x | 9.80x | 9.64x | 4.26x | 2.89x | 2.23x | 6.13x | 46.41x | 88.37x | 18.11x | 4.70x | 2.56x | 0.93x | 0.82x | 1.04x | 1.42x | 1.81x | 1.81x | 1.92x | 2.29x |
| Debt / EBITDA | 3.04x | 3.06x | 2.11x | 4.44x | 4.75x | 4.20x | 5.52x | 6.18x | 6.08x | 7.53x | 7.27x | 7.74x | 6.55x | 8.98x | 4.45x | 4.09x | 3.84x | 4.35x | 1.79x | 1.88x | - | 13.12x | - | - | 1.65x | 2.03x | 2.97x | 3.65x | 3.26x | 6.87x | 4.01x |
| Net Debt / EBITDA | 2.36x | 2.39x | 1.67x | 4.08x | 4.48x | 3.56x | 4.66x | 6.07x | 5.91x | 7.22x | 6.93x | 7.55x | 6.44x | 8.89x | 4.15x | 3.98x | 3.46x | 3.65x | 1.60x | 1.66x | - | 9.37x | - | - | 1.62x | 2.00x | 2.95x | 3.64x | 3.25x | 6.82x | 3.91x |
| Interest Coverage | 4.28x | 4.41x | 7.35x | 2.79x | 2.51x | 3.05x | 1.67x | 1.32x | 1.63x | 0.90x | 1.25x | 1.16x | 1.19x | 0.67x | 1.81x | 1.44x | 1.37x | 1.46x | 1.13x | 0.74x | -0.54x | -0.02x | -0.48x | -0.40x | 4.04x | 1.40x | 1.20x | 1.26x | 2.22x | - | 15.13x |
| Total Equity | 8.85B | 8.97B | 8.55B | 5.51B | 4.61B | 4.26B | 2.89B | 1.99B | 2.11B | 2.4B | 3.48B | 3.22B | 1.19B | 1.13B | 1.23B | 1.51B | 1.82B | 697M | 103M | 54M | 264M | 1.02B | 1.73B | 4.36B | 5.3B | 4.07B | 4.09B | 3.56B | 3.22B | 2.64B | 1.99B |
| Equity Growth % | 20.5% | 4.98% | 55.17% | 19.53% | 8.25% | 47.35% | 45.25% | -5.6% | -12.39% | -30.79% | 7.79% | 171.84% | 5.42% | -8.83% | -18.17% | -17.1% | 160.98% | 576.7% | 90.74% | -79.55% | -74.14% | -41.05% | -60.28% | -17.73% | 30.37% | -0.56% | 14.92% | 10.36% | 22.31% | 32.73% | 50.45% |
| Book Value per Share | 101.03 | 98.79 | 87.32 | 52.56 | 41.70 | 39.21 | 27.19 | 19.24 | 20.28 | 23.91 | 34.99 | 32.51 | 11.83 | 11.07 | 11.33 | 12.43 | 12.98 | 5.50 | 0.86 | 0.46 | 2.24 | 8.71 | 14.86 | 37.40 | 43.21 | 34.43 | 34.79 | 30.46 | 28.27 | 32.91 | 26.34 |
| Total Shareholders' Equity | 4.81B | 4.22B | 4.17B | 1.61B | 1.14B | 1.03B | 28M | -371M | -119M | -147M | 417M | 691M | 651M | 755M | 1.14B | 1.42B | 1.77B | 646M | 103M | 54M | 264M | 1.02B | 1.73B | 4.36B | 5.3B | 4.07B | 4.09B | 3.56B | 3.22B | 2.64B | 1.99B |
| Common Stock | 8M | 8M | 8M | 8M | 8M | 8M | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 7M | 27M | 27M | 27M | 26M | 26M | 26M | 26M | 26M | 26M | 25M | 24M | 24M | 0 | 0 | 0 | 0 |
| Retained Earnings | 5.12B | 4.42B | 3.01B | -192M | -803M | -1.21B | -2.13B | -2.47B | -2.24B | -2.39B | -1.74B | -1.55B | -1.41B | -1.42B | -1.29B | -1.44B | -1.52B | -2.67B | -2.85B | -2.88B | -2.61B | -1.81B | -930M | 1.71B | 2.51B | 1.63B | 1.57B | 1.08B | 819M | 1.09B | 740M |
| Treasury Stock | -5.26B | -4.94B | -3.54B | -2.86B | -2.66B | -2.41B | -2.41B | -2.41B | -2.41B | -2.42B | -2.42B | -2.42B | -2.38B | -2.38B | -1.98B | -1.85B | -1.48B | -1.48B | -1.48B | -1.48B | -1.48B | -1.48B | -1.48B | -1.49B | -257M | -70M | -70M | -70M | 0 | 0 | 0 |
| Accumulated OCI | -179M | -181M | -180M | -181M | -181M | -233M | -281M | -257M | -223M | -204M | -258M | -164M | -182M | -24M | -68M | -52M | -43M | -32M | -37M | -28M | -45M | -39M | -13M | -8M | -44M | -70M | 2.56B | -1.76B | -1.43B | -950M | -824M |
| Minority Interest | 4.04B | 4.75B | 4.38B | 3.9B | 3.47B | 3.23B | 2.86B | 2.36B | 2.23B | 2.55B | 3.06B | 2.53B | 535M | 370M | 91M | 85M | 53M | 51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High goodwill and leverage
As reported in recent financial statements, Tenet's total assets have expanded from $28.3 billion in 2023Q4 to $31.2 billion in 2026Q1, reflecting a strategic pivot toward higher-margin ambulatory assets that appears to be gradually improving the company's overall equity position and long-term financial stability.
The steady growth in total assets alongside a significant recovery in retained earnings suggests that management's divestiture strategy is successfully shedding lower-quality hospital assets. Investors should monitor whether this trajectory continues to reduce the company's historical reliance on debt-funded expansion.
Based on reported figures, Tenet has successfully reduced its debt-to-equity ratio from a peak of 2.72 in 2023Q4 to 1.49 in 2026Q1, signaling a meaningful deleveraging effort that may enhance the company's financial flexibility in a volatile interest rate environment.
While the absolute debt level has remained relatively stable near $13.2 billion, the improvement in the D/E ratio is primarily driven by the strengthening of the equity base. This trend warrants further investigation to determine if the company can maintain this momentum without sacrificing necessary capital expenditures.
According to quarterly filings, goodwill accounts for $11.4 billion of the $31.2 billion total asset base as of 2026Q1, indicating that a substantial portion of the company's valuation is tied to intangible premiums from past acquisitions rather than tangible medical infrastructure.
The high concentration of goodwill relative to net PPE suggests that the balance sheet is sensitive to potential impairment charges if the acquired ambulatory surgery centers fail to meet performance expectations. This reliance on intangible assets may mask the true replacement cost of the company's operational footprint.
As indicated by recent balance sheet data, Tenet's current ratio has fluctuated between 1.36 and 1.78 over the last ten quarters, suggesting that the company maintains an adequate liquidity buffer to manage short-term operational obligations despite the inherent volatility of the healthcare services sector.
The maintenance of a current ratio consistently above 1.3 suggests that management is prioritizing cash preservation to navigate potential labor cost spikes or regulatory shifts. Investors should monitor whether this liquidity is being deployed efficiently or if it is simply accumulating as a defensive measure.
Based on the provided financial data, Tenet's retained earnings have improved from a deficit of $192 million in 2023Q4 to a positive $5.1 billion by 2026Q1, which appears to be a primary driver of the company's strengthening equity position and overall balance sheet health.
This rapid accumulation of retained earnings suggests that the core business is generating sufficient profitability to offset historical losses and support internal growth. However, the sustainability of this trend may depend on the company's ability to manage non-controlling interests and ongoing divestiture-related costs.
Quick answers to the most common questions about buying THC stock.
As of 2025, Tenet Healthcare Corporation (THC) had total assets of $29.68B including $7.85B in current assets.
Tenet Healthcare Corporation (THC) carries total debt of $13.17B, offset by $2.88B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Tenet Healthcare Corporation (THC) has total shareholders' equity (book value) of $4.22B ($98.79 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Tenet Healthcare Corporation (THC) reported a current ratio of 1.76x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.